• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Echo-Coat needles

Article

STS Biopolymers of Rush, NY, has received 510(k) clearance for its line of Echo-Coat needles for ultrasound-guided biopsy applications. The needles are coated with a biocompatible polymer material that acts like an ultrasound contrast agent, providing a

STS Biopolymers of Rush, NY, has received 510(k) clearance for its line of Echo-Coat needles for ultrasound-guided biopsy applications. The needles are coated with a biocompatible polymer material that acts like an ultrasound contrast agent, providing a clear picture of the needle under ultrasound guidance, according to the company. STS believes that Echo-Coat will prompt physicians to use ultrasound for guiding biopsy procedures, rather than more expensive technologies like MRI or CT.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.